COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

NACompletedINTERVENTIONAL
Enrollment

332

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

January 21, 2022

Study Completion Date

January 21, 2022

Conditions
SARS-CoV2 InfectionCOVID-19
Interventions
DEVICE

iCura COVID-19 Antigen Rapid Home Test

Candidate Ag self-test kit anterior nasal specimen collection and testing will be done under the supervision of qualified site personnel in person. Comparator NP samples shall be collected at least 15 minutes prior to Ag samples with at least 15 minutes between nasal collections including collections that may occur prior to study enrollment. Comparator samples will be collected first by qualified personnel at a study site or physician's office using an FDA authorized nasopharyngeal swab collection kit and SARS-CoV-2 molecular assay.

DEVICE

RT-PCR Test

High sensitivity RT-PCR COVID-19 Test

Trial Locations (4)

32607

Daniel Sarkis, Gainesville

32720

Accel Research, DeLand

33709

Accel Research Site St. Petersburg, St. Petersburg

37919

EDP Biotech Corporation, Knoxville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

New Day Diagnostics

NETWORK

lead

MP Biomedicals, LLC

INDUSTRY